Utsugi T - Search Results

1

Pleural mesothelioma instigates tumor-associated fibroblasts to promote progression via a malignant cytokine network.

Li Q, Wang W, Yamada T, Matsumoto K, Sakai K, Bando Y, Uehara H, Nishioka Y, Sone S, Iwakiri S, Itoi K, Utsugi T, Yasumoto K, Yano S. Li Q, et al. Among authors: utsugi t. Am J Pathol. 2011 Sep;179(3):1483-93. doi: 10.1016/j.ajpath.2011.05.060. Epub 2011 Jul 18. Am J Pathol. 2011. PMID: 21763682 Free PMC article.

2

Therapeutic efficacy of a new topoisomerase I and II inhibitor TAS-103, against both P-glycoprotein-expressing and -nonexpressing drug-resistant human small-cell lung cancer.

Parajuli P, Yano S, Nishioka Y, Nokihara H, Hanibuchi M, Nishimura N, Utsugi T, Sone S. Parajuli P, et al. Among authors: utsugi t. Oncol Res. 1999;11(5):219-24. Oncol Res. 1999. PMID: 10608616

3

Up- and down-regulation of human lymphokine (IL-2)-activated killer cell induction by monocytes, depending on their functional state.

Nii A, Sone S, Utsugi T, Yanagawa H, Ogura T. Nii A, et al. Among authors: utsugi t. Int J Cancer. 1988 Jan 15;41(1):33-40. doi: 10.1002/ijc.2910410108. Int J Cancer. 1988. PMID: 2826345

4

Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.

Utsugi T, Sone S. Utsugi T, et al. J Immunol. 1986 Feb 1;136(3):1117-22. J Immunol. 1986. PMID: 3079797

5

Differential effects of recombinant interferons alpha, beta, and gamma on induction of human lymphokine (IL-2)-activated killer activity.

Sone S, Utsugi T, Nii A, Ogura T. Sone S, et al. Among authors: utsugi t. J Natl Cancer Inst. 1988 May 18;80(6):425-31. doi: 10.1093/jnci/80.6.425. J Natl Cancer Inst. 1988. PMID: 3130488

6

Tumor cytotoxicity and interleukin 1 production of blood monocytes of lung cancer patients.

Sone S, Utsugi T, Tandon P, Yanagawa H, Okubo A, Ogura T. Sone S, et al. Among authors: utsugi t. Cancer Immunol Immunother. 1990;30(6):357-62. doi: 10.1007/BF01786885. Cancer Immunol Immunother. 1990. PMID: 2302725 Free PMC article.

7

Effector mechanism of human monocyte-mediated cytotoxicity: role of a new tumor cytotoxic factor distinct from interleukin 1 and tumor necrosis factor alpha.

Sone S, Munekata M, Tanaka M, Utsugi T, Ogura T. Sone S, et al. Among authors: utsugi t. Biotherapy. 1989;1(3):233-43. doi: 10.1007/BF02170892. Biotherapy. 1989. PMID: 2642026

8

Lack of production of interleukin 1 by human blood monocytes activated to the antitumor state by liposome-encapsulated muramyl tripeptide.

Tandon P, Utsugi T, Sone S. Tandon P, et al. Among authors: utsugi t. Cancer Res. 1986 Oct;46(10):5039-44. Cancer Res. 1986. PMID: 3489519

9

[Augmentation of natural killer (NK) cell activity in human blood lymphocytes by a new synthetic acyltripeptide (FK-565) and its derivatives].

Shimizu E, Tandon P, Utsugi T, Sone S. Shimizu E, et al. Among authors: utsugi t. Gan To Kagaku Ryoho. 1986 Jul;13(7):2353-7. Gan To Kagaku Ryoho. 1986. PMID: 3460529 Japanese.

10

Induction of human monocyte-mediated tumor cell killing by a plant lectin, wheat germ agglutinin.

Ogawara M, Utsugi T, Yamazaki M, Sone S. Ogawara M, et al. Among authors: utsugi t. Jpn J Cancer Res. 1985 Nov;76(11):1107-14. Jpn J Cancer Res. 1985. PMID: 2418002

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters